AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Medical/Disease Research/Clinical Labs MED

regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); reauthorization of FDA user fees; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (S 2852/HR 6378); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2018 and FY2019; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 and FY2019 (S3158); H.R.1625 Vehicle for Consolidated Appropriations Act 2018; Medicare reimbursement of clinical laboratory services

Contacted: Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Food & Drug Administration (FDA)

Bills named: H.R. 1625 (115th), H.R. 6378 (115th)

Disaster Planning/Emergencies DIS

commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (S 2852/HR 6378)

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 6378 (115th)

Health Issues HCR

regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); reauthorization of FDA user fees; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (S 2852/HR 6378); Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2018 and FY2019; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 and FY2019 (S3158); H.R.1625 Vehicle for Consolidated Appropriations Act 2018; Medicare reimbursement of clinical laboratory services

Contacted: Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1625 (115th), H.R. 6378 (115th)

Medicare/Medicaid MMM

reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, implementation of the Protecting Access to Medicare Act (P.L. 113-93); reauthorization of FDA user fees; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 and FY2019 (S3158); H.R.1625 Vehicle for Consolidated Appropriations Act 2018; Medicare reimbursement of clinical laboratory services

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD); White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1625 (115th)

Budget/Appropriations BUD

regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); reauthorization of FDA user fees; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2018 and FY2019; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018 and FY2019 (S3158); H.R.1625 Vehicle for Consolidated Appropriations Act 2018; Medicare reimbursement of clinical laboratory services

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Defense, Dept of (DOD); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 1625 (115th)